AngioDynamics shares fall after naming Eric Honroth CEO
AngioDynamics appointed Eric Honroth as its next chief executive, effective Nov. 2, with the shares down 20% to $11.34 at midday Thursday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.